MarketCap
Facebook
X
TelegramQuartalsbericht 2025-Q3
hinzugefügt 31.10.2025
Merus N.V. P/S 2011-2025 | MRUS
P/S Jährlich Merus N.V.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 82.5 | 57.1 | 20.4 | 19.4 | 26.9 K | 13.1 | 7.67 | 24.3 | 234 | - | - | - | - | - |
Alle Zahlen in USD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 26.9 K | 7.67 | 3.04 K |
P/S anderer Aktien in der Pharmaeinzelhändler
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Arbutus Biopharma Corporation
ABUS
|
24.5 | $ 4.95 | 4.99 % | $ 822 M |  Canada |
 |
MorphoSys AG
MOR
|
1.75 | - | 2.43 % | $ 254 M |  Germany |
 |
Aclaris Therapeutics
ACRS
|
8.13 | $ 3.2 | -1.48 % | $ 247 M |  USA |
 |
Aptevo Therapeutics
APVO
|
3.11 | $ 1.06 | -5.97 % | $ 293 K | USA |
 |
Catalyst Biosciences
CBIO
|
0.296 | $ 13.19 | -6.39 % | $ 868 M | USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
5.53 | - | - | $ 40.3 B | USA |
 |
Ascendis Pharma A/S
ASND
|
947 | $ 213.99 | -2.92 % | $ 5 B |  Danmark |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.39 K | - | -1.52 % | $ 24.7 M | USA |
 |
Midatech Pharma plc
MTP
|
137 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alterity Therapeutics Limited
ATHE
|
131 | $ 3.1 | -5.93 % | $ 7.46 B |  Australia |
 |
Celldex Therapeutics
CLDX
|
0.187 | $ 27.04 | -1.73 % | $ 1.74 M | USA |
 |
Corcept Therapeutics Incorporated
CORT
|
9.7 | $ 87.29 | -0.8 % | $ 9.01 B | USA |
 |
Catalyst Pharmaceuticals
CPRX
|
4.96 | $ 24.46 | 3.56 % | $ 2.9 B | USA |
 |
CureVac N.V.
CVAC
|
281 | $ 5.04 | -0.3 % | $ 938 M | Germany |
 |
Институт стволовых клеток человека
ISKJ
|
2.61 | - | - | - |  Russia |
 |
Dynavax Technologies Corporation
DVAX
|
6.24 | $ 10.87 | 0.63 % | $ 1.41 B | USA |
 |
Acasti Pharma
ACST
|
0.203 | - | 4.01 % | $ 150 M | Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
34 | - | -15.15 % | $ 60.3 M | Britain |
 |
BioNTech SE
BNTX
|
35.7 | $ 94.19 | -0.66 % | $ 27.2 B | Germany |
 |
Aeglea BioTherapeutics
AGLE
|
489 | - | - | $ 1.01 B | USA |
 |
Albireo Pharma
ALBO
|
13.3 | - | -0.23 % | $ 916 M | USA |
 |
Alpine Immune Sciences
ALPN
|
8.94 | - | - | $ 2.17 B | USA |
 |
Ampio Pharmaceuticals
AMPE
|
106 | - | -11.43 % | $ 502 K | USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.79 | $ 26.28 | 4.0 % | $ 1.27 B | USA |
 |
Anika Therapeutics
ANIK
|
2.24 | $ 9.64 | 0.84 % | $ 141 M | USA |
 |
Eton Pharmaceuticals
ETON
|
3.61 | $ 15.96 | -4.43 % | $ 409 M | USA |
 |
Evogene Ltd.
EVGN
|
71.3 | $ 1.05 | -2.78 % | $ 27.9 M |  Israel |
 |
Can-Fite BioPharma Ltd.
CANF
|
759 | $ 0.27 | -6.29 % | $ 588 M | Israel |
 |
Foghorn Therapeutics
FHTX
|
11.1 | $ 4.39 | -1.13 % | $ 241 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
105 K | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
253 | - | 3.77 % | $ 22.4 M | USA |
 |
Acer Therapeutics
ACER
|
25.8 | - | 2.71 % | $ 14 M | USA |
 |
Axon Enterprise
AXON
|
19.1 | $ 548.77 | -2.75 % | $ 41.6 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
11.2 | - | - | $ 7.46 M | Israel |
 |
Aytu BioScience
AYTU
|
0.237 | $ 2.36 | 2.61 % | $ 14.8 M | USA |
 |
AstraZeneca PLC
AZN
|
2.17 | $ 91.51 | 1.87 % | $ 96.9 B | Britain |
 |
Acorda Therapeutics
ACOR
|
0.142 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
1.42 | - | -5.38 % | $ 6.06 M | USA |
 |
Burford Capital Limited
BUR
|
6.35 | $ 8.95 | -0.56 % | $ 1.45 B | Britain |
 |
BeiGene, Ltd.
BGNE
|
66.4 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
18.6 | $ 11.28 | -2.17 % | $ 730 M | USA |
 |
Biogen
BIIB
|
2 | $ 174.19 | 0.05 % | $ 25.4 B | USA |
 |
Abeona Therapeutics
ABEO
|
42.7 | $ 5.07 | -5.5 % | $ 108 M | USA |